BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 30883858)

  • 1. Gene expression profiling of lichenoid dermatitis immune-related adverse event from immune checkpoint inhibitors reveals increased CD14
    Curry JL; Reuben A; Szczepaniak-Sloane R; Ning J; Milton DR; Lee CH; Hudgens C; George S; Torres-Cabala C; Johnson D; Subramanya S; Wargo JA; Mudaliar K; Wistuba II; Prieto VG; Diab A; Tetzlaff MT
    J Cutan Pathol; 2019 Sep; 46(9):627-636. PubMed ID: 30883858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypertrophic lichenoid dermatitis immune-related adverse event during combined immune checkpoint and exportin inhibitor therapy: A diagnostic pitfall for superficially invasive squamous cell carcinoma.
    Marques-Piubelli ML; Tetzlaff MT; Nagarajan P; Duke TC; Glitza Oliva IC; Ledesma DA; Aung PP; Torres-Cabala CA; Wistuba II; Prieto VG; Nelson KC; Curry JL
    J Cutan Pathol; 2020 Oct; 47(10):954-959. PubMed ID: 32394425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene expression profiling and multiplex immunofluorescence analysis of bullous pemphigoid immune-related adverse event reveal upregulation of toll-like receptor 4/complement-induced innate immune response and increased density of T
    Marques-Piubelli ML; Seervai RNH; Mudaliar KM; Ma W; Milton DR; Wang J; Muhlbauer A; Parra ER; Solis LM; Nagarajan P; Speiser J; Hudgens C; Cho WC; Aung PP; Patel A; Pacha O; Nelson KC; Tetzlaff MT; Amaria RN; Torres-Cabala CA; Prieto VG; Wistuba II; Curry JL
    J Cutan Pathol; 2023 Jul; 50(7):661-673. PubMed ID: 37150813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lichenoid dermatitis from immune checkpoint inhibitor therapy: An immune-related adverse event with mycosis-fungoides-like morphologic and molecular features.
    Tetzlaff MT; Tang S; Duke T; Grabell DA; Cabanillas ME; Zuo Z; Yao JC; Nagarajan P; Aung PP; Torres-Cabala CA; Duvic M; Prieto VG; Huen A; Curry JL
    J Cutan Pathol; 2019 Nov; 46(11):872-877. PubMed ID: 31254410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics of circulating monocytes at baseline and after activation in patients with intracranial aneurysm.
    Wang J; Cao Y
    Hum Immunol; 2020 Jan; 81(1):41-47. PubMed ID: 31735443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Toll-Like Receptor 4 on Human Monocyte Subsets and Vulnerability Characteristics of Coronary Plaque as Assessed by 64-Slice Multidetector Computed Tomography.
    Ozaki Y; Imanishi T; Hosokawa S; Nishiguchi T; Taruya A; Tanimoto T; Kuroi A; Yamano T; Matsuo Y; Ino Y; Kitabata H; Kubo T; Tanaka A; Akasaka T
    Circ J; 2017 May; 81(6):837-845. PubMed ID: 28344199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of Toll-like receptor (TLR)2 and TLR4 on CD14dimCD16+ monocytes in response to sepsis-related antigens.
    Skinner NA; MacIsaac CM; Hamilton JA; Visvanathan K
    Clin Exp Immunol; 2005 Aug; 141(2):270-8. PubMed ID: 15996191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expansion and preferential activation of the CD14(+)CD16(+) monocyte subset during multiple sclerosis.
    Chuluundorj D; Harding SA; Abernethy D; La Flamme AC
    Immunol Cell Biol; 2014 Jul; 92(6):509-17. PubMed ID: 24638064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frontline Science: CXCR7 mediates CD14
    Veenstra M; Williams DW; Calderon TM; Anastos K; Morgello S; Berman JW
    J Leukoc Biol; 2017 Nov; 102(5):1173-1185. PubMed ID: 28754798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expanded CD14
    Zhang R; Shi J; Zhang R; Ni J; Habtezion A; Wang X; Hu G; Xue J
    J Immunol; 2019 May; 202(9):2578-2584. PubMed ID: 30894427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of CNS Viral Seeding by HIV
    Veenstra M; León-Rivera R; Li M; Gama L; Clements JE; Berman JW
    mBio; 2017 Oct; 8(5):. PubMed ID: 29066542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extracorporeal elimination of TNF-alpha-producing CD14(dull)CD16(+) monocytes in leukocytapheresis therapy for ulcerative colitis.
    Kanai T; Makita S; Kawamura T; Nemoto Y; Kubota D; Nagayama K; Totsuka T; Watanabe M
    Inflamm Bowel Dis; 2007 Mar; 13(3):284-90. PubMed ID: 17206704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulatory effects of CD14+CD16++ monocytes on CD14++CD16- monocytes: a possible explanation of monocyte alterations in systemic lupus erythematosus.
    Burbano C; Vasquez G; Rojas M
    Arthritis Rheumatol; 2014 Dec; 66(12):3371-81. PubMed ID: 25168844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential expression of Toll-like receptor 4 and human monocyte subsets in acute myocardial infarction.
    Kashiwagi M; Imanishi T; Ozaki Y; Satogami K; Masuno T; Wada T; Nakatani Y; Ishibashi K; Komukai K; Tanimoto T; Ino Y; Kitabata H; Akasaka T
    Atherosclerosis; 2012 Mar; 221(1):249-53. PubMed ID: 22244044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD14(hi)CD16+ monocytes phagocytose antibody-opsonised Plasmodium falciparum infected erythrocytes more efficiently than other monocyte subsets, and require CD16 and complement to do so.
    Zhou J; Feng G; Beeson J; Hogarth PM; Rogerson SJ; Yan Y; Jaworowski A
    BMC Med; 2015 Jul; 13():154. PubMed ID: 26149666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcript profiling of CD16-positive monocytes reveals a unique molecular fingerprint.
    Frankenberger M; Hofer TP; Marei A; Dayyani F; Schewe S; Strasser C; Aldraihim A; Stanzel F; Lang R; Hoffmann R; Prazeres da Costa O; Buch T; Ziegler-Heitbrock L
    Eur J Immunol; 2012 Apr; 42(4):957-74. PubMed ID: 22531920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relation among anti-rheumatic drug therapy, CD14(+)CD16(+) blood monocytes and disease activity markers (DAS28 and US7 scores) in rheumatoid arthritis: A pilot study.
    Amoruso A; Sola D; Rossi L; Obeng JA; Fresu LG; Sainaghi PP; Pirisi M; Brunelleschi S
    Pharmacol Res; 2016 May; 107():308-314. PubMed ID: 27045818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subgroups of monocytes predict cardiovascular events in patients with coronary heart disease. The PHAMOS trial (Prospective Halle Monocytes Study).
    Höpfner F; Jacob M; Ulrich C; Russ M; Simm A; Silber RE; Girndt M; Noutsias M; Werdan K; Schlitt A
    Hellenic J Cardiol; 2019; 60(5):311-321. PubMed ID: 31055050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maximal Exercise Alters the Inflammatory Phenotype and Response of Mononuclear Cells.
    Slusher AL; Zúñiga TM; Acevedo EO
    Med Sci Sports Exerc; 2018 Apr; 50(4):675-683. PubMed ID: 29112629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating CD14+ CD16+ monocytes are expanded in sarcoidosis patients.
    Okamoto H; Mizuno K; Horio T
    J Dermatol; 2003 Jul; 30(7):503-9. PubMed ID: 12928539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.